The inhibition of eukaryotic aminoacyl transferase I by chartreusin.
D000217:Acyltransferases / Q000037:antagonists & inhibitors* / Q000097:blood / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001578:Benzopyrans; D006027:Glycosides / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000378:metabolism / Q000494:pharmacology; D006571:Heterocyclic Compounds / Q000494:pharmacology; D010445:Peptide Elongation Factors / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D010649:Phenylalanine / Q000378:metabolism / Q000494:pharmacology; D010759:Phosphorus Isotopes; D011072:Poly U / Q000494:pharmacology; D011691:Puromycin / Q000378:metabolism; D012343:RNA, Transfer / Q000378:metabolism / Q000494:pharmacology; D011817:Rabbits; D011868:Radioisotopes; D012156:Reticulocytes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D012270:Ribosomes / Q000187:drug effects / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D001578:Benzopyrans; D006027:Glycosides; D006571:Heterocyclic Compounds; D010445:Peptide Elongation Factors; D010759:Phosphorus Isotopes; D011868:Radioisotopes; D011072:Poly U; D010649:Phenylalanine; D011691:Puromycin; D006160:Guanosine Triphosphate; D012343:RNA, Transfer; D000217:Acyltransferases; C002185:chartreusin